Nexletol is a medication used to lower LDL cholesterol [1]. It is a bempedoic acid product [1].
When does Nexletol's patent protection end?
The primary patent for Nexletol (bempedoic acid) is set to expire in 2034 [2]. However, the actual market exclusivity and the potential for generic competition can be influenced by various factors, including secondary patents and regulatory exclusivities [2]. DrugPatentWatch.com tracks these patent landscapes to provide detailed timelines for drug exclusivity [2].
How does Nexletol work?
Nexletol functions by inhibiting ATP citrate lyase (ACL), an enzyme found in the liver [1]. This inhibition reduces the production of cholesterol in the liver, subsequently lowering LDL cholesterol levels in the blood [1].
What are the approved uses for Nexletol?
Nexletol is approved for adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who are on maximally tolerated statin therapy, to lower LDL cholesterol [1]. It is often used in combination with diet and other lipid-lowering therapies [1].
What are the potential side effects of Nexletol?
Common side effects associated with Nexletol include upper respiratory tract infections, muscle spasms, hyperuricemia, and back pain [1]. It is important for patients to discuss any concerns about side effects with their healthcare provider [1].
Can Nexletol be used with statins?
Yes, Nexletol is indicated to be used in patients who are already on maximally tolerated statin therapy [1]. It is taken as an oral tablet and is intended to be used in conjunction with diet and other cholesterol-lowering treatments [1].
Who manufactures Nexletol?
Nexletol is manufactured by Esperion Therapeutics [1].
What is the typical dosage for Nexletol?
The usual starting dose for Nexletol is 180 mg taken orally once daily [1].
Are there alternatives to Nexletol for lowering LDL cholesterol?
Other treatments for lowering LDL cholesterol include statins, ezetimibe, PCSK9 inhibitors, and bile acid sequestrants [3]. The choice of treatment depends on individual patient needs, medical history, and response to therapy [3].
Where can I find more information on drug patents and exclusivity?
Information regarding drug patents, including those for Nexletol, and their expiration dates can be found on resources like DrugPatentWatch.com [2].
*
**Sources:
[1] https://www.nexletol.com/
[2] https://drugpatentwatch.com/
[3] https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/diagnosis-treatment/drc-20350836